Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
9.43B | 9.16B | 8.55B | 7.24B | 7.11B | Gross Profit |
6.13B | 5.95B | 5.51B | 4.68B | 4.62B | EBIT |
2.86B | 2.68B | 2.32B | 1.88B | 1.52B | EBITDA |
3.11B | 3.31B | 3.06B | 2.62B | 2.46B | Net Income Common Stockholders |
1.93B | 1.78B | 1.63B | 1.47B | 1.22B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
119.00M | 155.00M | 334.00M | 113.00M | 88.00M | Total Assets |
15.13B | 14.92B | 15.83B | 13.86B | 14.14B | Total Debt |
6.54B | 6.50B | 6.73B | 6.17B | 7.12B | Net Debt |
6.42B | 6.34B | 6.40B | 6.05B | 7.04B | Total Liabilities |
11.63B | 11.48B | 12.07B | 10.63B | 12.04B | Stockholders Equity |
3.48B | 3.46B | 3.78B | 3.23B | 2.10B |
Cash Flow | Free Cash Flow | |||
2.59B | 1.98B | 1.97B | 1.68B | 1.23B | Operating Cash Flow |
2.61B | 2.46B | 2.40B | 2.02B | 1.60B | Investing Cash Flow |
-575.00M | -569.00M | -859.00M | -384.00M | -1.17B | Financing Cash Flow |
-2.06B | -2.06B | -1.33B | -1.61B | -474.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
77 Outperform | $95.92B | 39.35 | 56.34% | 2.14% | 5.86% | 13.13% | |
77 Outperform | $93.33B | 34.98 | 34.01% | 1.42% | 10.77% | 8.38% | |
76 Outperform | $8.88B | 29.72 | 16.68% | 1.32% | 6.85% | 21.26% | |
72 Outperform | $9.41B | 17.73 | 10.99% | 2.86% | -0.59% | 24.06% | |
68 Neutral | £2.89B | 10.32 | 8.40% | 3.42% | 3.06% | -9.96% | |
67 Neutral | $509.71M | 32.05 | 1.92% | 4.18% | -3.10% | -58.47% | |
46 Neutral | $2.35B | 28.35 | 11.28% | 3.25% | -11.77% | ― |